Teewinot Life Sciences: Teewinot Life Sciences Announces Executive Leadership Changes

TAMPA, Fla., May 22, 2019 (GLOBE NEWSWIRE) -- Teewinot Life Sciences Corporation, a global leader in the biosynthetic development and production of cannabinoids and their derivatives for health and wellness needs, today announced recent changes to the executive leadership team:Michael Luther, Ph.D., MBA has joined Teewinot as president and chief executive officerSteve Orndorff, Ph.D. has joined the company as chief operating officerJeff Mathiesen, CPA has joined the company as chief financial officerCollectively, the new management team brings decades of experience in successfully building and leading biopharmaceutical life sciences companies, as well as significant expertise in drug development."We are privileged to have such an esteemed group of biotech industry veterans join and lead Teewinot as the company embarks on the next stage of growth, specifically the advancement of our impressive proprietary platform for the development and manufacturing of an unprecedented range of cannabinoids," said Charles Brink, J.D., chairman of the board of Teewinot. "With the addition of Michael, Steve and Jeff to the senior management team, we are confident that Teewinot will continue to lead the industry in the generation and production of biosynthetic cannabinoids for both therapeutics and consumer health products."Dr. Luther added, "I am excited and honored to join Teewinot as President and CEO. I look forward to guiding the company as we advance our revolutionary cannabinoid platform. Teewinot's approach uniquely addresses the ...Full story available on Benzinga.com